Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy

被引:186
作者
Vega, RB
Rothermel, BA
Weinheimer, CJ
Kovacs, A
Naseem, RH
Bassel-Duby, R
Williams, RS
Olson, EN
机构
[1] Univ Texas, SW Med Ctr, Dept Biol Mol, Dallas, TX 75390 USA
[2] Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA
[3] Washington Univ, Dept Med, Cardiovasc Res Ctr, St Louis, MO 63110 USA
[4] Duke Univ, Sch Med, Off Dean, Durham, NC 27710 USA
关键词
D O I
10.1073/pnas.0237225100
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The calcium/calmodulin-dependent protein phosphatase calcineurin stimulates cardiac hypertrophy in response to numerous stimuli. Calcineurin activity is suppressed by association with modulatory calcineurin-interacting protein (MCIP)1/DSCR1, which is up-regulated by calcineurin signaling and has been proposed to function in a negative feedback loop to modulate calcineurin activity. To investigate the involvement of MCIP1 in cardiac hypertrophy in vivo, we generated MCIP1 null mice and subjected them to a variety of stress stimuli that induce cardiac hypertrophy. in the absence of stress, WIN1(-/-) animals exhibited no overt phenotype. However, the lack of MCIP1 exacerbated the hypertrophic response to activated calcineurin expressed from a muscle-specific transgene, consistent with a role of MCIP1 as a negative regulator of calcineurin signaling. Paradoxically, however, cardiac hypertrophy in response to pressure overload or chronic adrenergic stimulation was blunted in MCIP1(-/-) mice. These findings suggest that MCIP1 can facilitate or suppress cardiac calcineurin signaling depending on the nature of the hypertrophic stimulus. These opposing roles of MCIP have important implications for therapeutic strategies to regulate cardiac hypertrophy through modulation of calcineurin-MCIP activity.
引用
收藏
页码:669 / 674
页数:6
相关论文
共 27 条
[1]   INHIBITOR-2 FUNCTIONS LIKE A CHAPERONE TO FOLD 3 EXPRESSED ISOFORMS OF MAMMALIAN PROTEIN PHOSPHATASE-1 INTO A CONFORMATION WITH THE SPECIFICITY AND REGULATORY PROPERTIES OF THE NATIVE ENZYME [J].
ALESSI, DR ;
STREET, AJ ;
COHEN, P ;
COHEN, PTW .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 213 (03) :1055-1066
[2]   Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo [J].
Antos, CL ;
McKinsey, TA ;
Frey, N ;
Kutschke, W ;
McAnally, J ;
Shelton, JM ;
Richardson, JA ;
Hill, JA ;
Olson, EN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (02) :907-912
[3]   Impaired cardiac hypertrophic response in calcineurin Aβ-deficient mice [J].
Bueno, OF ;
Wilkins, BJ ;
Tymitz, KM ;
Glascock, BJ ;
Kimball, TF ;
Lorenz, JN ;
Molkentin, JD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (07) :4586-4591
[4]   Dscr1, a novel endogenous inhibitor of calcineurin signaling, is expressed in the primitive ventricle of the heart and during neurogenesis [J].
Casas, C ;
Martínez, S ;
Pritchard, MA ;
Fuentes, JJ ;
Nadal, M ;
Guimerà, J ;
Arbonés, M ;
Flórez, J ;
Soriano, E ;
Estivill, X ;
Alcántara, S .
MECHANISMS OF DEVELOPMENT, 2001, 101 (1-2) :289-292
[5]   NFAT signaling: Choreographing the social lives of cells [J].
Crabtree, GR ;
Olson, EN .
CELL, 2002, 109 :S67-S79
[6]   Cardiac hypertrophy: The good, the bad and the ugly [J].
Frey, N ;
Olson, EN .
ANNUAL REVIEW OF PHYSIOLOGY, 2003, 65 :45-79
[7]   A NEW HUMAN GENE FROM THE DOWN-SYNDROME CRITICAL REGION ENCODES A PROLINE-RICH PROTEIN HIGHLY EXPRESSED IN FETAL BRAIN AND HEART [J].
FUENTES, JJ ;
PRITCHARD, MA ;
PLANAS, AM ;
BOSCH, A ;
FERRER, I ;
ESTIVILL, X .
HUMAN MOLECULAR GENETICS, 1995, 4 (10) :1935-1944
[8]   Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene [J].
Fuentes, JJ ;
Pritchard, MA ;
Estivill, X .
GENOMICS, 1997, 44 (03) :358-361
[9]   Identification and characterization of a highly conserved calcineurin binding protein, CBP1/calcipressin, in Cryptococcus neoformans [J].
Görlach, J ;
Fox, DS ;
Cutler, NS ;
Cox, GM ;
Perfect, JR ;
Heitman, J .
EMBO JOURNAL, 2000, 19 (14) :3618-3629
[10]   Targeted inhibition of calcineurin in pressure-overload cardiac hypertrophy - Preservation of systolic function [J].
Hill, JA ;
Rothermel, B ;
Yoo, KD ;
Cabuay, B ;
Demetroulis, E ;
Weiss, RM ;
Kutschke, W ;
Bassel-Duby, R ;
Williams, RS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (12) :10251-10255